Remove 2017 Remove Communication Remove Compounding
article thumbnail

Gaps Remain in MOUD Access Across Opioid Treatment Programs

Drug Topics

From 2017 to 2023, the percentage of all opioid treatment programs offering 3 forms of medication for opioid use disorder (OUD) increased from 33% to 45%, but there is still a need to expand the offerings of OUD therapy across treatment programs. 1 Data from 10,289 facility-year observations were used, with 1211 in 2017 and 1421 in 2023.

article thumbnail

FDA Approves GSK’s Shingles Vaccine in Prefilled Syringe

Drug Topics

Shingrix was initially approved by the FDA in 2017 for the prevention of shingles in adults aged 50 years or older. October 23, 2017. 1 “The FDA approval is a positive step toward driving prevention of this painful disease, and as a practicing pharmacist I welcome the availability of this new presentation.” News Release. July 17, 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

OTC Case Studies: Summer Skin Care

Pharmacy Times

She is deeply passionate about embracing the pillars of lifestyle medicine, self-care, effective communication, and inclusivity to create lasting positive health and wellness outcomes. Updated July 14, 2017. It should be reapplied after being in the water; otherwise, it may need to be applied every 2 hours while they are on the beach.

article thumbnail

Overdose Deaths Begin to Sustain Decline After Decades Long Increase

Drug Topics

Between January 2015 and September 2017, monthly drug overdose deaths increased steadily but plateaued from September 2017 to September 2019. The study authors said that the 12-month moving sum of the drug overdose death rate ranged from 14.54 per 100,000 population in January 2015 to a peak of 33.24 in August 2023.

article thumbnail

Cell and gene therapy: The vital role of logistics

Pharmaceutical Technology

The projected growth of the cell and gene therapy market GlobalData estimates that the cell and gene therapy market will achieve global sales of $76.03bn by 2030, up from $5.88bn in 2023, with a compound annual growth rate (CAGR) of 44% over the seven years analysed. of the global market, valued at $39.3bn.

article thumbnail

Allergic-Related Skin Diseases Significantly Increased Since 1990

Drug Topics

2 Not as prominent, urticaria was reported to impact 86 million people in 2017, which was around 1.1% Of the allergic-related skin diseases, AD is one of the most prominent, impacting more than 204 million people globally, or 2.6% of the population. of the population.

article thumbnail

The digital transformation of pharma’s physician engagement strategies

pharmaphorum

The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The threat of disease spread and other risk factors from COVID-19 have only compounded this.